Cargando…
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
BACKGROUND: As trials of 5 years of tamoxifen in early breast cancer mature, the relevance of hormone receptor measurements (and other patient characteristics) to long-term outcome can be assessed increasingly reliably. We report updated meta-analyses of the trials of 5 years of adjuvant tamoxifen....
Autor principal: | Early Breast Cancer Trialists' Collaborative Group (EBCTCG) |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lancet Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163848/ https://www.ncbi.nlm.nih.gov/pubmed/21802721 http://dx.doi.org/10.1016/S0140-6736(11)60993-8 |
Ejemplares similares
-
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
por: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Publicado: (2012) -
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
por: EBCTCG (Early Breast Cancer Trialists' Collaborative Group)
Publicado: (2014) -
Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the ‘Arimidex™ and Tamoxifen Alone or in Combination’ (ATAC) trial
por: Trialists' Group, The ATAC
Publicado: (2001) -
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies
por: Collaborative Group on Epidemiological Studies of Ovarian Cancer
Publicado: (2015) -
Tamoxifen resistance and adjuvant hormone therapy
por: Howell, A
Publicado: (2005)